2 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Celtic Pharma Development Services: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tolerability Study of Xerecept® in Pediatric Patients XERECEPT - Brain Edema, Brain Tumor | Phase 1 / Phase 2 | Terminated | Celtic Pharma Development Services | 15 | 2010-06-01 | 2013-07-30 |
| Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE) Xerecept - Peritumoral Brain Edema, PRIMARY MALIGNANT and METASTATIC BRAIN TUMORS | Phase 2 | Terminated | PharmaNet | 60 | 2008-11-01 | 2009-01-09 |
Brain Neoplasms (2) · Brain Edema (1) · Edema (1)
Corticotropin-Releasing Hormone (1)
United States (1)